Sana Biotechnology, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
Sana Biotechnology, Inc. has filed 386 SEC EDGAR filings since 26 Jun 2020

SEC filing history

Showing 276-300 of 386 matching filings.

Per page
25
Current page
12
DEF 14A File 001-39941

DEF 14A

Filing date
26 Apr 2022
Reporting date
06 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Apr 2022
Reporting date
14 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Apr 2022
Reporting date
05 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Apr 2022
Reporting date
05 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Mar 2022
Reporting date
21 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2022
Reporting date
03 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2022
Reporting date
03 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2022
Reporting date
03 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2022
Reporting date
03 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2022
Reporting date
03 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2022
Reporting date
03 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Feb 2022
Reporting date
18 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92124

SC 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92124

SC 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92124

ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92124

SC 13G/A filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92124

SC 13G filing

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39941

8-K - NIH AND JPM

Filing date
11 Jan 2022
Reporting date
07 Jan 2022
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Sep 2021
Reporting date
15 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Sep 2021
Reporting date
10 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .